Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.
Role of tumor necrosis factor-alpha in zebrafish retinal neurogenesis and myelination.
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2.
Thrombin and Protein C Pathway in Peripheral Nerve Schwann Cells.
Brain atrophy measurements should be used to guide therapy monitoring in MS - Commentary.
Familial amyotrophic lateral sclerosis with an I104F mutation in the SOD1 gene: Multisystem degeneration with neurofilamentous aggregates and SOD1 inclusions.
'Non-criteria' neurologic manifestations of antiphospholipid syndrome: A hidden kingdom to be discovered.
Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
The neuroinflammatory component of gray matter pathology in multiple sclerosis.
Dysautonomic polyneuropathy as a variant of chronic inflammatory "demyelinating" polyneuropathy?
Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.
An Unusual Case of Myelitis with Myositis.
Epidermal growth factor preserves myelin and promotes astrogliosis after intraventricular hemorrhage.
Combined effects of transferrin and thyroid hormone during oligodendrogenesis In vitro.
Between genetics and biology. Is ENMG useful in peripheral neuropathy diagnosis and management?
Imaging Manifestations of Neurologic Complications in Anemia.
Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke.
Social isolation impairs remyelination in mice through modulation of IL-6.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report.
Multiple sclerosis: Immune reconstitution effective for MS.
Soil heavy metals are associated with the distribution of multiple sclerosis in Isfahan, Iran.
Design, synthesis and docking studies of novel 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents.
Traumatic brain injury: a risk factor for neurodegenerative diseases.
Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis.
Pages
« first
‹ previous
…
774
775
776
777
778
779
780
781
782
…
next ›
last »